Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Sales (2017 - 2026)

Integra Lifesciences Holdings' Return on Sales history spans 17 years, with the latest figure at 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for Integra Lifesciences Holdings, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for IART hit a ceiling of 0.0% in Q4 2022 and a floor of 0.01% in Q2 2025.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
  • Biggest five-year swings in Return on Sales: changed 0bps in 2021 and later decreased -1bps in 2025.
  • Tracing IART's Return on Sales over 5 years: stood at 0.0% in 2021, then rose by 19bps to 0.0% in 2022, then plummeted by -62bps to 0.0% in 2023, then dropped by -12bps to 0.0% in 2024, then tumbled by -109bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for IART at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.01% in Q2 2025.